Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy.
about
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-AnalysisCombination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models.Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy.Assessment of health-related quality of life in Japanese patients with metastatic renal cell carcinoma during treatment with tyrosine kinase inhibitors.
P2860
Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Improved survival in patients ...... n the era of targeted therapy.
@en
type
label
Improved survival in patients ...... n the era of targeted therapy.
@en
prefLabel
Improved survival in patients ...... n the era of targeted therapy.
@en
P2093
P2860
P1476
Improved survival in patients ...... in the era of targeted therapy
@en
P2093
Hideaki Miyake
Iori Sakai
Masato Fujisawa
P2860
P2888
P304
P356
10.1007/S10147-013-0612-Z
P577
2013-08-30T00:00:00Z